International safety notice

Ortho Clinical Diagnostics

United Kingdom / MHRA · GBR · Jun 30, 2022

Key facts

Title Ortho Clinical Diagnostics
Regulator United Kingdom / MHRA
Country GBR
Brand Blood Grouping Reagent Anti-Lea (Anti-LE1)
Manufacturer Ortho Clinical Diagnostics
Models ANTI-LE1, CL2022-164A_EU, 6901859, 10-SEP-2023, 30-JUL-2022, LAB169AX, LAB170AX.ORTHO, 2.0PRODUCT, 23-JUL-2023, 10758750007271, 14-MAY-2023, LAB168AX and 3 more
Event type Safety Notice
Action type Field safety notice
Date Jun 30, 2022
Regulator page gov.uk

At a glance

  • No Recall
  • Yes Field safety notice

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About International device safety notices

Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.

Source: National medical device regulators (as listed), compiled by Orca1

Browse all International device safety notices